We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

136 hedge funds and large institutions have $268M invested in SANGAMO THERAPEUTICS INC in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

363% more call options, than puts

Call options by funds: $5.67M | Put options by funds: $1.23M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 42

5% less funds holding

Funds holding: 143 → 136 (-7)

8% less capital invested

Capital invested by funds: $289M → $268M (-$21.8M)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

Holders
136
Holders Change
-7
Holders Change %
-4.9%
% of All Funds
3.63%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
40
Reduced
42
Closed
21
Calls
$5.67M
Puts
$1.23M
Net Calls
+$4.45M
Net Calls Change
+$943K

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$8.94M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.14M
3
AC
Ascend Capital
California
+$2.65M
4
Millennium Management
Millennium Management
New York
+$2.35M
5
NI
Numeric Investors
Massachusetts
+$2.28M

Top Sellers

Rank Fund Capital Flow
1
EAM
EverPoint Asset Management
Connecticut
-$9.07M
2
RCM
RA Capital Management
Massachusetts
-$6.67M
3
FCMI
Foresite Capital Management III
California
-$3.3M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.48M
5
SCM
Sio Capital Management
New York
-$2.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
51
T. Rowe Price Associates
Maryland
$570K +$114K +17,900 +22%
Goldman Sachs
52
Goldman Sachs
New York
$548K +$167K +26,184 +38%
AIC
53
AWM Investment Company
New York
$534K – – –
AllianceBernstein
54
AllianceBernstein
Tennessee
$529K – – –
New York State Common Retirement Fund
55
New York State Common Retirement Fund
New York
$520K +$168K +26,350 +41%
Wellington Management Group
56
Wellington Management Group
Massachusetts
$495K -$288K -45,200 -35%
KeyBank National Association
57
KeyBank National Association
Ohio
$470K +$58.7K +9,215 +13%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$450K +$34.2K +5,370 +7%
OAM
59
Oxford Asset Management
United Kingdom
$448K -$2.14M -335,702 -81%
HCM
60
Highbridge Capital Management
New York
$402K +$442K +69,404 New
WS
61
Wedbush Securities
California
$356K -$3.19K -500 -0.8%
State Board of Administration of Florida Retirement System
62
State Board of Administration of Florida Retirement System
Florida
$354K – – –
ProShare Advisors
63
ProShare Advisors
Maryland
$353K +$2.33K +365 +0.6%
First Eagle Investment Management
64
First Eagle Investment Management
New York
$347K -$2.04M -319,727 -84%
FSA
65
Franklin Street Advisors
North Carolina
$310K – – –
Nisa Investment Advisors
66
Nisa Investment Advisors
Missouri
$297K +$191K +30,000 +141%
GT
67
Glenmede Trust
Pennsylvania
$290K -$6.05K -950 -2%
WC
68
Wexford Capital
Florida
$286K – – –
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$286K +$19.8K +3,114 +7%
BCM
70
Bourgeon Capital Management
Connecticut
$284K +$35.1K +5,500 +13%
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$277K – – –
DC
72
Davenport & Co
Virginia
$265K – – –
NFA
73
Nationwide Fund Advisors
Ohio
$257K – – –
HCM
74
Highlander Capital Management
New Jersey
$249K -$6.37K -1,000 -2%
LCM
75
Leisure Capital Management
California
$246K +$351 +55 +0.1%
1 2
3
4 5

SGMO Hedge Fund Activity: Q2 2016 in Review

136 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2016, worth a combined $268M — down 7.5% from $289M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of SGMO and 14 opened new positions — a net loss of 7 holders — while 42 trimmed existing stakes and 40 added.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $8.94M. The largest seller was EverPoint Asset Management, exiting entirely with an estimated $9.07M sold.

  • 136 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2016, down from 143 in Q1 2016.
  • Funds reported $268M of SANGAMO THERAPEUTICS INC stock for Q2 2016, down 7.5% quarter-over-quarter.
  • 14 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2016 and 21 closed out, a net change of -7 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2016 was Cormorant Asset Management, an estimated $8.94M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2016 was EverPoint Asset Management, an estimated $9.07M sold.

Based on aggregated 13F filings for Q2 2016.